CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371858472
- Phone
- (847) 787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- 4 Open-market sale 10% owner sold 165,100 shares at an average $5.03 ($830,670)
- 4 Open-market buy CFO, Treasurer & Secretary bought 5,000 shares at $4.43 ($22,150)
- 4 Open-market buy President & CEO bought 10,000 shares at $4.32 ($43,200)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale 10% owner sold 604,500 shares at an average $5.83 ($3,523,187)
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 4/A Open-market sale 10% owner sold 105,000 shares at $8.07 ($847,350)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale 10% owner sold 105,000 shares at $8.07 ($847,350)
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market buy President & CEO bought 5,000 shares at $5.96 ($29,800)
- 8-K Event Other events
- 8-K Event Other events
- 4 Open-market sale 10% owner sold 242,300 shares at an average $8.52 ($2,064,511)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
Page 14 of 22 · 426 filings